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Objective: The aim of this study was to examine the effects of high weight loss on knee joint loads during
walking in participants with knee osteoarthritis (OA).
Design: Data were obtained from a subset of participants enrolled in the Arthritis, Diet, and Activity
Promotion Trial (ADAPT). Complete baseline and 18-month follow-up data were obtained on 76 seden-
tary, overweight or obese older adults with radiographic knee OA. Three-dimensional gait analysis was
used to calculate knee joint forces and moments. The cohort was divided into high (>5%), low (<5%), and
no (0% or gain) weight loss groups.
Results: From baseline body weight, the high weight loss group lost an average of 10.2%, the low weight
loss group lost an average of 2.7%, and the no weight loss group gained 1.5%. Adjusted 18-month outcome
data revealed lower maximum knee compressive forces with greater weight loss (P ¼ 0.05).
The difference in compressive forces between the high weight loss and no weight loss groups was
due primarily to lower hamstring forces (P¼ 0.04). Quadriceps forces were similar between the groups at
18-month follow-up. There was no difference between the groups in 18-month joint space width or
KellgreneLawrence scores.
Conclusions: These results suggest that a 10% weight loss in an overweight and obese osteoarthritic
population elicits positive changes in the mechanical pathway to knee OA by having lower knee joint
compressive loads during walking compared to low and no weight loss groups. The difference in
compressive forces was due, in large part, to reductions in hamstring co-contraction during the initial
portion of the stance phase.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.The most important modiﬁable risk factor for development and
progression of knee osteoarthritis (OA) is obesity1e8. Weight loss
reduces the risk of symptomatic knee OA4 and may have important
implications for mortality risk9. Weight loss combined with exer-
cise is recommended for obese knee OA sufferers by both the
American College of Rheumatology (ACR) and the European League
Against Rheumatism (EULAR)10,11.
We have shown a signiﬁcant and direct correlation between
weight loss and attenuation of knee joint forces and moments
during walking in this population12. A reduction of 1 lb in body
weight was associated with a four times larger loss in knee jointStephen P. Messier, J.B. Snow
xercise Science, Wake Forest
s Research Society International. Pcompressive forces. This implies that the greater the intentional
weight loss, the lower the stress on the knee, thereby enhancing the
potential of slowing disease progression and improving clinical
outcomes. Indeed, mechanical factors are implicated in the path-
ogenesis of knee OA, and obesity plays a role in this pathway by
increasing joint loads13. As a result, there is increased tissue
damage, cartilage loss, pain, and ultimately, disability.
Our previous work was limited to low-to-moderate weight loss.
A moderate, 5% weight loss, when combined with exercise,
improved function and pain but was not a sufﬁcient stimulus to
slow disease progression14. The purpose of this exploratory analysis
was to use a selected subset from our previous study14 (i.e., those
with complete biomechanical observations) to expand the bound-
aries of weight loss to larger, potentially more clinically meaningful
amounts to provide evidence whether high weight loss in older
overweight and obese adults with knee OA consequent toublished by Elsevier Ltd. All rights reserved.
S.P. Messier et al. / Osteoarthritis and Cartilage 19 (2011) 272e280 273participation in an 18-month diet and exercise clinical trial reduces
knee joint loads and attenuates disease progression relative to low
weight loss, and no weight loss or weight gain.
Patients and methods
Design
ADAPT was a single-blind, randomized controlled clinical trial of
overweight and obese sedentary older adultswith symptomatic knee
OA14,15. The studywas designed to compare the effects of assignment
to four distinct 18-month interventions: (1) exercise, (2) dietary
weight loss (diet), (3) dietary weight loss plus exercise (diet-plus-
exercise), and (4) healthy lifestyle (control). ADAPTwas conducted at
the ClaudeD. Pepper Older Americans Independence Center ofWake
Forest University, with the approval of the university’s institutional
review board and in accordance with the Helsinki Declaration.
Participants
Sedentary, overweight and obese, older adults with radiographic
evidence of knee OA were recruited in six waves over an 18-month
period. Detailed inclusion and exclusion criteria are noted else-
where14,15. Brieﬂy, inclusion criteria included: (1) age 60 years;
(2) overweight or obese (BodyMass Index (BMI) 28.0 kgm2); (3)
radiographicevidence inoneorbothkneesofKellgreneLawrence (KL)
grades IeIII tibio-femoral OA inweight-bearing anteroposterior view
and/or patellofemoral OA in sunrise view; (4) nomore than 20min of
regular exercise perweek; (5) self-report of knee pain onmost days of
themonth; (6) self-report of difﬁculty due to knee pain inone ormore
daily activities (e.g., walking one-quarter mile, shopping, bending,
etc); and (7) willingness to undergo testing and intervention proce-
dures. Exclusion criteria included: (1) serious co-morbid medical
condition that could prevent safe participation in an exercise
program; (2) score of <24 on Mini-Mental State Exam (MMSE);
(3) inability or unwillingness to modify dietary and/or exercise
behaviors; (4) inability to complete the 18-month studyor probability
ofnoncompliance; (5) inability towalkwithout a caneorotherassistive
device; (6) participation in another interventional research study; (7)
self-reported alcohol consumption of >14 drinks/week; or (8) ST-
segment depression of>2mmat an exercise level of fourMETs or less,
hypotension or complex arrhythmias during a graded exercise test16.
A total of 316 individuals were randomized to one of the four
treatment groups. A subset of this population (n¼ 142), equally
represented in the four intervention groups, was randomized to
ancillary biomechanics testing. The descriptive characteristics of the
biomechanics subsetwere similar to those of the entire ADAPTcohort
and are presented elsewhere12 with a ﬂowchart of participant prog-
ress. Testing was conducted at baseline, 6- and 18-month follow-up.
For this study, only participants who had complete baseline and 18-
month biomechanical data were included (N¼ 76). There was no
signiﬁcant difference (P¼ 0.17) in baseline Western Ontario and
McMaster Universities Osteoarthritis Index (WOMAC) function
between the subset of participants with and without complete
ancillary data. We compared participants who lost more than 5% of
their baselineweight (n¼ 24) to thosewho lost less than 5% (n¼ 23),
and who did not lose or gained weight (n¼ 29) at the end of 18
months. The following analyses include all 76 participants and group
comparisons based on all participants, and on the 53 participants at
the higher and lower end of the weight loss (gain) distribution.
Interventions
The exercise, diet, exercise-plus-diet, and healthy lifestyle
interventions are described in detail elsewhere14,15. Participantsrandomized to either exercise or diet-plus-exercise interventions
were prescribed a 3-days/week exercise regimen combining
aerobic (walking) and resistance training. The 60-min workout
consisted of a 15-min aerobic phase, a 15-min resistance training
phase, a second 15-min aerobic phase, and a 15-min cool-down.
The dietary therapy intervention focused on reducing fat and
total calories. Participants were taught to evaluate and to modify
food intake, with less than 30% of calories derived from fat. The
weight-loss goal was 5% of the participants’ body weight.
The diet-plus-exercise group combined the therapy programs
outlined above. The healthy lifestyle intervention served as the
attention control group and provided social interaction and health
education. Three monthly 1-h presentations on topics related to
knee OA, obesity, and exercise were followed by monthly (months
4e6), then bimonthly (months 7e18) phone calls.
Prior to participation, the experimental procedures were
explained to each participant and an informed consent document
was signed.
Measurements and procedures
Gait analysis
Prior to testing at baseline and 18-month follow-up visits,
participants’ freely chosen walking speeds were assessed using
a Lafayette Model 63501 photoelectric control system interfaced
with a digital timer. The photocells were positioned 7.3 m apart on
an elevated walkway. Participants traversed the 7.3 m course six
times. Freely chosen walking speed was calculated as the mean of
the six trials. This speed (3.5%) was used in all subsequent gait
evaluations for the particular test period.
To control for the effects of footwear, each participant wore an
identical make and model athletic shoe during testing. Three-
dimensional (3D) high-speed (60 Hz) videography was performed
using a four-camera motion analysis system (Motion Analysis
Corporation, Santa Rosa, CA). Raw coordinate data from the 3D
system was smoothed using a Butterworth low-pass digital ﬁlter
with a cut-off frequency of 6 Hz. Temporal and lower extremity
kinematic and kinetic variables were computed using Orthotrak
software and an Advanced Mechanical Technologies Inc (AMTI)
model SGA6-4 force platform (AMTI, Watertown, MA) set to sample
data at 1000 Hz. Three successful trials, in which the participant
walked within 3.5% of freely chosen speed and placed the entire
foot on the force platform in a visually normal stride, were averaged
to yield representative values. Kinematic and kinetic data were
synchronized, which allowed calculation of net joint forces and
moments at the lower extremity joints through standard inverse
dynamic techniques (e.g., Winter17). A biomechanical model was
subsequently used to calculate knee muscle and joint forces from
the net joint forces and moments, the kinematic data, and related
anatomical and physiological characteristics. The model is
described in detail in the Appendix. The outcomes were the peak
values of seven knee joint kinetic variables: compressive and
anteroposterior shear forces, hamstrings, quadriceps and gastroc-
nemius forces, the internal knee extension and abductionmoments.
Knee radiographs
Bilateral anteroposterior weight-bearing knee radiographs were
used to assess the presence of tibiofemoral arthritis, and bilateral
sunrise views were used to assess the presence of patellofemoral
arthritis. Both radiographs were obtained at baseline and
18 months. The weight-bearing radiographs were obtained with
the participant’s knees ﬂexed at a 15 angle. The X-ray beam was
centered on the joint space. Foot maps were used at baseline and
follow-up to assure similar positioning for the two radiographs. The
focus-to-ﬁlm distance was held constant throughout the study.
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graphs paired for each subject. Severity of tibiofemoral OAwas deter-
mined using the KL grading scale (0¼ no disease; 1¼ questionable;
2¼ deﬁnite; 3¼moderate; 4¼ severe)18. Medial and lateral joint
space widths were measured by determining the smallest distances
between the cortical margins of the tibia and femur for each
compartment using a 10magnifying lens and a 0.1 mmgraded ruler.
Statistical analysis
Statistical analyses were performed using SAS. Three weight loss
groups were created: more than 5% weight loss at the end of
18months (High), 0.1e5%weight loss (Low), andno change orweight
gain (No). Fischer’s exact test revealed that the allocation of subjects
to the threeweight classiﬁcationswasnot dependenton intervention
group assignment (P ¼ 0.29). Baseline analyses included descriptive
statistics consisting of frequency tables and percents for categorical
variables and means and standard deviations (SDs) for
continuous variables. Bivariate plots were used to describe associa-
tions betweenweight loss and outcomes. Analysis of covariance was
used to obtain estimates ofweight loss effects at 18-month follow-up
adjusting for pre-randomization levels of the baseline value of the
outcome being analyzed, age, gender, walk speed and ADAPT inter-
vention. Models include all 3 groups, overall P-value, and the P-value
comparing the highweight loss group to the groupwith no change or
weight gain. Corresponding 18-month change is reported from
models with change as the dependent variable and the same inde-
pendent variables as described above. Percent change is obtained by
dividing the change by the baseline mean. These analyses were
conducted at the 0.05 two-sided level of signiﬁcance.
Results
Retention
Of the 142 participants randomized to biomechanics testing, 116
(82%) had complete data for at least one follow-up biomechanical
visit (at 6 and/or 18 months). Only participants who had complete
baseline and 18-month biomechanical and weight loss data were
included (N¼ 76). The proportion of participants that completed
ancillary biomechanics 18-month testing was lower than the
completion rate for the primary outcome of the entire ADAPTcohort
(80%). This was due, in large part, to the additional burdenplaced on
these participants that included both biomechanics and strength
testing. There was no signiﬁcant difference (P¼ 0.17) in baseline
WOMAC function between those who completed the biomechanics
testing (23.8 1.28) and those who did not (26.61.55).
Weight loss
Baseline and 18-month follow-up values for body weight are
shown in Table I. Baselineweight ranged from 70 kg to 148 kg in the
high weight loss group, from 69 kg to 118 kg in the low weight loss
group, and from 67 kg to 117 kg in the no weight loss group.
The high weight loss group lost an average of 10.2% (9.5 kg) ofTable I
Mean (95% CI) weight and weight loss values at baseline and 18 months follow-up for th
Weight loss N Baseline weight (kg) 18-month
High 24 93.0 (85.9; 100.0) 83.4 (76.9;
Low 23 89.7 (83.6; 95.7) 87.2 (81.4;
No 29 94.8 (90.2; 99.4) 96.2 (91.7;
Weight loss: high¼27% to 5.1 %, low¼5% to 0.01%, none¼ 0% to 7.5%
CI¼ Conﬁdence Intervalbaseline body weight, the low weight loss group lost 2.7% (2.5 kg),
and the no weight loss group gained 1.5% (1.3 kg).
Walking velocity
Baseline walking velocities were similar between the high
weight loss (1.17 0.04 ms1), low weight loss (1.210.04 ms1)
and no weight loss (1.20 0.04 ms1) groups. These groups
increased walking velocity by 6.8% (1.25 0.04 ms1), 7.4%
(1.30 0.04 ms1) and 4.2% (1.25 0.04 ms1), respectively, across
the 18-month intervention. There was no signiﬁcant (P¼ 0.59)
between-group difference at 18-month follow-up. The increase
over the 18-month intervention period was signiﬁcant in the high
and low weight loss groups (P¼ 0.04 and 0.003, respectively), but
not in the no weight loss group (P¼ 0.38).
Knee joint loads
Adjusted 18-month outcome data revealed lower maximum
knee compressive forces with greater weight loss (P¼ 0.05)
(Table II). This was due, in part, to the signiﬁcantly lower vertical
ground reaction forces (P¼ 0.003). In contrast, there were no
differences in AP shear forces between the groups. Internal knee
abduction moment, a surrogate measure of knee joint load in
previous studies, is an important component of the knee
compression force. The 18-month abduction moment values were
slightly lower in the high weight loss group compared to the low
and no weight loss groups, however, the differences were not
signiﬁcant. There was no difference in peak extension moments
between the groups over 18 months (Table II).
Maximum hamstring force was signiﬁcantly different
(P 0.03) among the 3 groups, with the high weight loss group
having lower values than both the low and no weight loss groups
(Table III). Quadriceps forces were similar between the groups at
18-month follow-up. All groups increased quadriceps force from
baseline. Gastrocnemius peak forces showed a non-signiﬁcant
dose response trend with greater weight loss resulting in lower
forces. The greatest difference in these forces was between the
high and the no weight loss groups (P¼ 0.10, ES¼ 0.45)
(Table III).
Radiographic progression
KL scores on the most affected knee at 18-month follow-up,
adjusted for baseline KL differences, were not statistically different
between the groups (P ¼ 0.44) (Table IV). In addition, there were
no between-group differences in medial or later joint space
widths.
Discussion
In our musculoskeletal model, the quadriceps, hamstrings, and
gastrocnemius muscle forces account for a major portion of the
knee compressive and shear forces as in other studies19e21. Hence,
any change in compressive or shear forces will be due, in large part,e high, low, and no weight loss groups
weight (kg) Change in weight (kg) %Δ
90.0) 9.5 (11.9; 7.1) 10.2 (12.3; 8.0)
92.9) 2.5 (3.1; 1.9) 2.7 (3.3; 2.2)
100.6) 1.3 (0.7; 2.0) 1.5 (0.8; 2.2)
Table II
Comparison of maximum knee joint loads (mean 95% CI) by weight loss group at 18-month follow-up, after adjusting for age, gender, walk speed, ADAPT intervention and
baseline value
Variable Weight loss Baseline Adjusted 18-month P-value Overall (High vs No) Δ % Δ
AP shear force (N) High 461 (377; 545) 585 (481; 689) 0.61 (0.44) 107.8 23.4
Low 453 (373; 533) 514 (404; 625) 37.5 8.3
No 512 (464; 559) 529 (429; 630) 52.4 10.2
Compressive force (N) High 2852 (2433; 3271) 2843 (2573; 3114) 0.05 (0.01) 75.2 2.6
Low 2908 (2628; 3188) 3049 (2755; 3342) 130.1 4.5
No 2969 (2678; 3261) 3310 (3050; 3570) 391.3 13.2
Abduction moment (Nm) High 38 (32; 44) 34 (28; 40) 0.65 (0.44) 2.8 7.4
Low 37 (30; 45) 37 (31; 43) 0.7 1.9
No 34 (29; 40) 37 (31; 49) 0.2 0.6
Extension moment (Nm) High 33 (21; 46) 34 (25; 43) 0.21 (0.72) 0.9 2.7
Low 41 (24; 58) 23 (13; 33) 12.4 30.3
No 32 (25; 39) 32 (23; 40) 3.3 10.4
Vertical ground reaction force (N) High 976 (860; 1092) 892 (830; 953) 0.003 (0.001) 135.7 13.9
Low 1118 (721; 1514) 949 (886; 1012) 78.6 7.0
No 993 (945; 1041) 1036 (983; 1089) 8.2 0.8
Weight loss: high¼27% to 5.1 %, low¼5% to 0.01%, none¼ 0 to 7.5%, Δ¼mean at month 18 e mean at baseline, % Δ¼ Δ/mean at baseline.
CI ¼ Conﬁdence Interval.
S.P. Messier et al. / Osteoarthritis and Cartilage 19 (2011) 272e280 275to changes in one of more of these muscle forces. Although quad-
riceps forces increased between 9% and 18% across the groups, the
highweight loss groupmaintained peak knee compressive forces at
baseline values, in part by reducing hamstring forces by 11%. This
did not occur in the low and no weight loss groups, resulting in
greater peak knee compressive forces relative to the high weight
loss group. We presume the reduction in hamstring and knee
compressive forces in the high weight loss group were caused by
the reduced total body weight, thereby decreasing the amount of
muscle force required to support and propel the subjects. Since
walk speed can also inﬂuence knee joint forces and moments,
we adjusted for group differences in our analyses. We do note
however, the beneﬁcial effect weight loss seemed to have on self-
selected walking speed; i.e., the low and high weight loss groups
increased walking speed ∼7%. Himann et al.22 noted that walk
speed declined 1e2% per decade of life until age 63 years, when the
decline per decade increased to 12.4% for females and 16.1% for
males. Hence, the increase in walking speed in our older adult
cohort suggests a slowing in the decline in mobility associated with
aging and knee OA consequent to long-term weight loss and/or
exercise interventions.
Intuitively, a reduction in body weight would lower the vertical
ground reaction forces. A mean weight loss exceeding 10% in the
high weight loss group resulted in lower peak vertical ground
reaction loads. Interestingly, these changes did not exactly coincide
with the changes observed in the knee compressive forces. Most
notably, the vertical ground reaction force was reduced after 18
months in the low weight loss group, but the knee joint
compressive force was actually increased from baseline to 18-
month follow-up. We suggest, therefore, that while the externalTable III
Comparison of maximum muscle forces (mean 95% CI) by weight loss group predicte
gender, walk speed, ADAPT intervention and baseline value
Variable Weight Loss Baseline Adju
Gastrocnemius force (N) High 673 (619; 728) 595
Low 657 (604; 711) 695
No 746 (693; 799) 703
Hamstring force (N) High 799 (665; 933) 697
Low 754 (644; 864) 864
No 821 (713; 930) 822
Quadriceps force (N) High 1292 (941; 1642) 1460
Low 1258 (1022; 1494) 1396
No 1340 (1136; 1545) 1520
CI ¼ Conﬁdence Interval.ground reaction force provides an approximation of joint loads,
observed changes over time may not be indicative of the actual
changes occurring within the joint.
Figure 1 shows the timing of peak compressive, quadriceps,
hamstring, and gastrocnemius forces during gait. The period of
greatest challenge for an older adult with knee OA occurs shortly
after heel strike during weight acceptance23. As shown through
electromyographic data, the quadriceps and the hamstrings
contract simultaneously (i.e., co-contract) to help stabilize the knee
during this challenging load bearing period, and this co-contraction
is increased in knee OA patients24e26. The hamstrings also lessen
the anterior shear force caused by the quadriceps, and control hip
extension throughout stance. The more co-contraction, however,
the greater the compressive forces exerted on the knee. Within the
limitations of our muscle force predictions (see Appendix below),
our data enable us to uniquely estimate co-contraction through the
relationship of actual muscle forces instead of muscle activation
patterns. These data suggest that with greater weight loss, osteo-
arthritic patients were able to reduce the level of co-contraction by
reducing hamstrings but not quadriceps force, thereby limiting the
compressive load exerted on the knee. Indeed, there was a signiﬁ-
cant dose response to weight loss, with the high weight loss group
having signiﬁcantly lower peak knee compressive forces relative to
the low and no weight loss groups at 18-month follow-up.
The gastrocnemius, as part of the triceps surae complex, acts
primarily to stabilize the ankle, restrain the rate of tibial advance-
ment throughout stance, and provide force at push off to support
and propel body mass23,27. Gastrocnemius forces peak during
terminal stance20,28,29 and, therefore, have more inﬂuence on the
magnitude of the second peak knee compressive force (see Fig. 1).d from the musculoskeletal model at 18-month follow-up, after adjusting for age,
sted 18-month P-value Overall (High vs No) Δ % Δ
(502; 688) 0.19 (0.10) 95.5 14.2
(595; 795) 4.7 0.7
(612; 796) 13.1 1.8
(607; 787) 0.03 (0.04) 88.4 11.1
(765; 963) 78.9 10.5
(738; 906) 36.7 4.5
(1165; 1754) 0.84 (0.76) 179.5 13.9
(1080; 1712) 116.1 9.2
(1240; 1799) 239.6 17.9
Table IV
Comparison of joint space width (mm) and KL score (mean 95% CI) at baseline and 18-month follow-up by weight loss group, after adjusting for age, gender, walk speed,
ADAPT intervention and baseline value
Variable Weight loss Baseline Adjusted 18-month P-value Overall (High vs No) Δ % Δ
Lateral joint space width (mm) High 4.56 (3.82; 5.30) 4.35 (3.89; 4.81) 0.46 (0.50) 0.137 3.0
Low 4.40 (3.75; 5.04) 4.50 (4.08; 4.92) 0.009 0.2
No 4.38 (3.69; 5.08) 4.16 (3.79; 4.53) 0.332 7.6
Medial joint space width (mm) High 3.17 (2.64; 3.69) 3.12 (2.88; 3.36) 0.67 (0.41) 0.120 2.6
Low 2.99 (2.21; 3.76) 3.00 (2.76; 3.25) 0.240 4.5
No 3.47 (3.00; 3.93) 2.99 (2.77; 3.20) 0.256 13.2
KL score High 2.36 (1.92; 2.79) 2.47 (2.30; 2.63) 0.44 (0.37) 0.149 6.3
Low 2.39 (1.98; 2.79) 2.61 (2.45; 2.77) 0.293 12.3
No 2.26 (1.97; 2.55) 2.56 (2.42; 2.70) 0.244 10.8
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a lesser extent, the ankle plantar ﬂexors among the highweight loss
participants suggest that the greater weight loss resulted in less co-
contraction for knee stabilization and reduced force requirements
for ankle stabilization, tibial advancement, and push off.
The high weight loss group had signiﬁcantly lower knee
compressive forces and was the only cohort that reduced the
internal knee abductionmoment, a surrogatemeasure of knee joint
loading, from baseline to follow-up. Reduced knee joint loading0
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Fig. 1. (A) Knee compressive, and (B) Hamstring, (C) Quadriceps, and (D) Gastrocne-
mius muscle forces of a complete stance phase of a typical participant. Note: 1 body
weight¼ 923.1 N (94.1 kg).through intense weight loss may play a role in slowing disease
progression by eliciting positive changes in the mechanical
pathway to knee OA. These mechanical improvements, however,
did not result in concomitant changes in disease progression.
Radiography is relatively insensitive to change and does not eval-
uate disease in soft tissue structures. A larger sample size, the use of
a more sensitive measure of progression, such as Magnetic Reso-
nance Imaging (MRI), or a longer intervention period (i.e., the effect
that weight loss has on progressionmay be evident sometime later)
may have enhanced our ability to detect differences in progression
among the groups.
Our previous study of dietary therapy and its effect on gait in
people afﬂicted with knee OA was limited to moderate weight
loss12. We expanded the boundaries of weight loss to larger,
potentially more clinically meaningful amounts and found that
higher weight loss than previously studied elicited beneﬁcial
effects. Speciﬁcally, high weight loss (mean¼ 10.2%) resulted in
lower knee joint compressive loads relative to low and no weight
loss or weight gain, primarily by reducing hamstring co-contraction
during the initial portion of the stance phase.
The importance of the aggressive use of non-pharmacologic co-
therapies such as intensive weight loss for improving symptoms
associated with OA, slowing disease progression, and impacting the
underlying mechanisms of OA is under appreciated. Our study
provides evidence that intensive long-term weight loss affords
biomechanical improvements in knee joint loads not seen in low or
no weight loss groups. Future study of long-term high intensity
weight loss as a possible OA disease modifying intervention is
needed using more sensitive measures of disease progression. The
potential beneﬁts of intensive weight loss for co-morbidities
common to obese, knee OA patients such as heart disease,
stroke, and type II diabetes enhance further the import of this non-
pharmacologic intervention.Author contributions
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Fig. 2. Schematic representation of the biomechanical musculoskeletal knee model
used to calculate knee joint loads and muscle forces (see Appendix for details).
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We used a biomechanical model of the knee to calculate total
compressive and anterioreposterior shear forces within the
tibio-femoral compartment of the knee joint. The model (see
Fig. 2) used lower extremity joint forces and moments calculated
with inverse dynamics along with the kinematics of the lower
extremity and related anatomical and physiological characteris-
tics to calculate forces in the three largest knee muscles and in
the lateral soft tissue support structures (e.g., lateral collateral
ligament). These forces were combined with the knee joint
reaction forces to determine the tibio-femoral compressive and
shear forces30,31. Gastrocnemius force was determined from the
plantar ﬂexor moment during the stance phase of gait. It was
assumed that this moment was produced by triceps surae
muscles (gastrocnemius and soleus). Triceps surae force was
calculated as the quotient of the plantar ﬂexor moment and the
moment arm for the triceps surae at the observed angular
position of the ankle. Muscle moment arm values for each ankle
position were derived from moment armeankle joint position
curves from the literature30,31. The mean value throughout the
ankle Range of Motion (ROM) for the moment arm was 0.051 m.
Gastrocnemius force was then partitioned from triceps surae
force based on its proportion of the total physiological cross
sectional area (PCA) of the triceps surae which was 0.31932.
These methods were supported by the strong association
between gastrocnemius Electromyography (EMG) and ankle
plantar ﬂexor torque33e36 and in directly measured force in
the Achilles tendon during walking37,38. The direction of the
gastrocnemius force was determined from the heel and knee
marker positions. The heel marker represented the distal end of
the gastrocnemius. The proximal end was positioned 0.020 m
superior and 0.023 m posterior to the knee joint, along the line of
the femur39. The resultant direction of the gastrocnemius force
was ∼3 from parallel with the leg and applied a relatively large
compressive load but small shear load on the knee.
Hamstrings force was calculated from the extensor moment at
the hip observed typically during the ﬁrst half of stance. This
method was supported by the strong association between hip
extensor moment and hamstrings EMG in early stance34,36,40. The
hip extensor moment was assumed to be produced by the
hamstrings and gluteus maximus muscles and it was assumed that
therewas no co-contraction of the hip ﬂexors during the ﬁrst half of
stance. This assumptionwas generally supported by EMGmeasures
and muscle force predictions in the literature except that rectus
femoris does partially contract and produce force during some of
this period40,41. The predicted hamstrings force accounted for both
the hamstrings PCA relative to the total PCA of the hamstrings and
gluteus maximus and the hamstrings moment arm at the hip
relative to the gluteus maximus moment arm. The total hamstrings
proportion to the hip moment were calculated as:
Hp ¼ ðHam PCA=ðHam PCA þ GM PCAÞÞðHd=GMdÞ (1)
where Hp is the proportion of the hip extensor moment generated
by the hamstrings, Ham PCA and GM PCAwere the hamstrings and
gluteus maximus PCAs, and Hd and GMd are the hamstrings and
gluteus maximus moment arms. Values for each of these constants
were obtained from the literature32,42 and were: Ham
PCA¼ 42.4 mm2, GM PCA¼ 17.36 mm2, Hd¼ 0.042 m, and GM
d¼ 0.047 m. The proportion of the hip extensor moment generated
by the hamstrings (Hp) was equal to 0.63 of the total moment. The
hamstrings force was then calculated as:
H ¼ HpðHetÞ=Hd (2)where H was the hamstrings force and Het was the hip extensor
moment. Hamstrings force was assumed to be zero when the hip
torquewas in the ﬂexor direction typically during the second half of
stance which is supported by hamstring EMG data24,36,43. The
hamstrings force was directed parallel to the femur.
The quadriceps force were calculated from the observed net
knee joint torque and the hamstrings and gastrocnemius forces and
thereby accounted for co-contracting knee ﬂexors. The observed
net knee torque was a function of all muscles crossing the joint:
Kt ¼ QðQdÞ  HðHdÞ  GðGdÞ (3)
where Kt was the net knee torque from inverse dynamics, Q, H, and
Gwere the forces by the quadriceps, hamstrings and gastrocnemius
muscles, and Qd, Hd, and Gd were the respective moment arms for
the muscles at the knee based on the observed knee angular
positions. The force in the quadriceps, Q, was then calculated as:
Q ¼ ðKtþ HðHdÞ þ GðGdÞÞ=Qd (4)
Moment arms at the knee were obtained from the literature by
averaging the values from a number of studies and for each angular
position of the knee joint31,44e47. The mean values throughout the
knee ROM for the three moment arms were, Qd¼ 0.035 m,
Hd¼ 0.032 m, and Gd¼ 0.018 m. The direction of Q was deter-
mined from the literature44,47 and was a function of knee angle.
The methods of Schipplein et al.48 were used to determine the
distribution of frontal plane loads and in particular the force in
the lateral support structures at the knee during the stance phase.
The external loads placed an adductor moment on the knee that
was resisted by a combination of abductor moments from the
quadriceps and the lateral structures. The quadriceps abductor
moment (product of the quadriceps force and its frontal plane lever
arm) was subtracted from the observed net internal abductor
moment calculated by inverse dynamics. The remaining moment
was distributed to the lateral knee tissues and the force in these
tissues was calculated as the quotient of this torque and its moment
arm. This force was considered to act parallel with the line of the
tibia.
The ﬁnal step was the calculation of knee joint forces. All muscle
forces, the force in the lateral support structures and the joint
reaction forces identiﬁed with inverse dynamics were partitioned
into their compressive (parallel with the tibia) and anteroposterior
shear (perpendicular to the tibia in the sagittal plane) components
and summed. The equations were:
Table V
Comparison of peak muscle forces from Fig. 1 and previous studies
Muscle force Present Winby et al. Wu et al.
Hamstrings force (N) 790 995 975
Quadriceps force (N) 1650 1600 2100
Gastrocnemius force (N) 780 1000 1480
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Kc ¼ Gcos aþ Hcos bþ Qcos f Kzcos lþ Kysin lþ Lss (6)
where Ks and Kc are the shear and compressive forces at the knee,
Kz and Ky were the vertical and horizontal knee joint reaction
forces, and Lss was the force in the lateral support structures. Ks
was positive when the shear force applied an anterior load to the
tibia and Kc was positive when the compressive force pushed into
the tibia.Limitations of biomechanical knee model
One limitation was the absence of several knee ligaments.
The absence of cruciate and medial collateral ligaments increased
the knee muscle force predictions since these tissues must resist
some of the external loads. However, we expected that total knee
loads were not severely affected because they were produced by
the sum of all tissues crossing the joint regardless of whether these
tissues are muscle or ligament. The model included the lateral
support tissues (e.g., collateral ligament) which is important and
produced the principle, non-muscular restraint during the stance
phase of walking.
A second limitation was the assumption of no co-contraction by
the hip ﬂexors and the hip abductors during stance. The assump-
tion of no co-contraction at the hip introduced some error due to
missing force production in the rectus femoris which also applied
force at the knee and the gluteus medius. This issue was relevant
during the initial part of the stance phase when the hamstrings
were active and produced force. Thesemissing forces would tend to
have opposite effects on hamstrings force (rectus femoris would
increase and gluteus medius would decrease hamstrings force).
Also, force in the rectus femoris during the ﬁrst half of stance and
relative EMG activation of this muscle are relatively low or even
absent28,49.We therefore propose that our error in hamstrings force
was relatively low. We performed a sensitivity analysis of the effect
of hamstring error on knee force predictions. An underestimate of
hamstrings force by 25% produced only a 5% error on knee force
predictions.
A third limitation is that our model is a, “lumped muscle
model,” and cannot distinguish muscle forces between smaller
muscle anatomical units. For example, we cannot uniquely
identify Vasti from rectus femoris forces or medial from lateral
Vasti muscles. Recent evidence showed that knee-OA patients
have adaptations in medial and lateral Vasti muscle electro-
myographic patterns25,50. Our model however cannot identify
underlying muscle forces associated with these activation
changes. Also, our model cannot partition knee joint forces into
lateral and medial compartment loads (as in20,28). This limitation
most likely led to a partial underestimation of the knee
compressive force.
Finally, our model may have underestimated the knee muscle
forces because it was limited to satisfying the condition of static
equilibrium but did not account for additional muscle forces due
to increased muscle activation in OA patients e.g.,25,26 This
limitation may have also led to slightly underestimating the total
knee compressive force. Overall, the combined limitations may
have produced an underestimation of knee joint forces and this
may explain the difference between the range of peak
compressive forces (3.2 BWe3.7 BW) in our current and
previous studies12,43 and the value (4.3 BW) recently reported by
Richards and Higginson21. When compared to a number of
recent studies, our values are well within the range of values
reported.Comparison of muscle and joint forces with other models
Our muscle force curves were similar in shape to those of Winby
et al.20 and Wu et al.51. Maximum hamstrings, quadriceps, and
gastrocnemius forces occurred at approximately 12%, 25%, and 80% of
the stancephase in eachmodel.Muscle force predictions varied among
themodels.Usingour representative subject (Fig.1), presentmaximum
hamstrings force was 20% less than reported in the other models,
quadriceps force were within 3% of the value reported byWinby et al.,
and our gastrocnemius forcewasmore similar to the value reported by
Winby et al. thanwas the value fromWu et al. (see Table V).
Except for the gastrocnemius force in Wu et al., all other values
were within 30% of one another and should be considered
reasonably similar considering that differences among the tested
populations in age, health status, and physical characteristics, along
with differences in walking speeds could readily account for
differences of this magnitude.
Predicted knee joint compressive forces were highly similar
among several models including the present model. All models
showed biphasic force curves with maximum values at approxi-
mately 30% and 80% of the stance phase. Our maximum force
predictionwas 24% higher than those by Kim et al. and Lin et al. and
was 16% lower than the prediction by Winby et al. Our prediction
was also within the 1 SD range reported in the Winby study and
nearly identical to the value reported by Taylor et al. of 3.2 BW.
It appears from the muscle and joint force comparisons that our
modeling procedures produce results as acceptable and as accurate
as those from other biomechanical models.References
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